Dupilumab Efficacy And Safety In Moderate To Severe Uncontrolled Asthma

Dupilumab is a completely human anti–interleukin-4 receptor monoclonal antibody. It blocks signaling from interleukin-4 as well as interleukin-13. In individuals with asthma that was not under control, we evaluated both its effectiveness and its safety. Dupilumab is a human monoclonal antibody that targets interleukin-4 (IL-4) and interleukin-13 (IL-13), two of the key cytokines that are […]

from ImNepal.com https://ift.tt/FyCjvps